title: Probiotic use in horses - what is the evidence for their clinical efficacy?
abstract: The gastrointestinal microbiota is extremely important for human and animal health. Investigations into the composition of the microbiota and its therapeutic modification have received increasing interest in human and veterinary medicine. Probiotics are a way of modifying the microbiota and have been tested to prevent and treat diseases. Probiotics are proposed to exert their beneficial effects through various pathways. Production of antimicrobial compounds targeting intestinal pathogens, general immune stimulation, and colonization resistance are among these mechanisms. Despite widespread availability and use, scientific, peer-reviewed evidence behind commercial probiotic formulations in horses is limited. Additionally, quality control of commercial over-the-counter products is not tightly regulated. Although promising in vitro results have been achieved, in vivo health benefits have been more difficult to prove. Whether the ambiguous results are caused by strain selection, dosage selection or true lack of efficacy remains to be answered. Although these limitations exist, probiotics are increasingly used because of their lack of severe adverse effects, ease of administration, and low cost. This review summarizes the current evidence for probiotic use in equine medicine. It aims to provide veterinarians with evidence-based information on when and why probiotics are indicated for prevention or treatment of gastrointestinal disease in horses. The review also outlines the current state of knowledge on the equine microbiota and the potential of fecal microbial transplantation, as they relate to the topic of probiotics.
authors.affiliation: Clinic for Equine Internal Medicine, University of Zurich, Zurich, Switzerland; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
authors.forename: A
authors.initials: A
authors.lastname: Schoster
authors.forename: J S
authors.initials: JS
authors.lastname: Weese
authors.forename: L
authors.initials: L
authors.lastname: Guardabassi
mesh_terms: D000818:Animals; D041981:Gastrointestinal Tract / Q000187:drug effects / Q000382:microbiology; D006734:Horse Diseases / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control*; D006736:Horses / Q000382:microbiology; D064307:Microbiota / Q000187:drug effects; D019936:Probiotics / Q000627:therapeutic use*
keywords: Bifidobacterium; Fecal microbial transfaunation; Lactobacillus; Microbiota